The FDA has accepted Otsuka’s New Drug Application for centanafadine, a first-in-class norepinephrine, dopamine and serotonin reuptake inhibitor (NDSRI) for the treatment of attention-deficit ...

With an expiration date still more than a year away, here's what the latest details reveal.

News and commentary from the psychiatry world ...

From 2022 to 2024, stimulant prescriptions issued in Connecticut increased by 13.2 percent, according to data from the state.

Please provide your email address to receive an email when new articles are posted on . Asian, Black and Hispanic children with ADHD were less likely to be prescribed medication early vs. white ...

When the NHS recognised ADHD in adults in 2008, never in my wildest hypochondriacal dreams did I imagine it applied to me. I fit the diagnostic criteria, including sleep problems, time blindness, ...

Taking ADHD medication might just save your life — and not in the way you’d expect. A groundbreaking study involving nearly 150,000 people reveals that those who take medication for their ADHD face ...

This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: ADHD and menopause symptoms can overlap, and one condition might exacerbate the other. Fluctuating ...

UK had highest relative increase of five countries in study, with 20-fold rise in proportion of women over 25 using it ...